newsNICE has issued its final appraisal decision recommending reimbursement of…
16 February 2018 | By European Pharmaceutical Review
NICE has issued its final appraisal decision recommending reimbursement of Lenvima for the treatment of progressive, locally advanced or metastatic, differentiated thyroid carcinoma...